The Latest Breaking News from MHRA

Here's a roundup of top developments in the biotech space over the last 24 hours:

‘Spikevax’ jab declared ‘safe and effective’ for this age group

The UK has become the first major country to approve Valneva's vaccine against covid-19

The Healthcare products Regulatory Agency (MHRA) of the U.K. has granted Conditional Marketing Authorization for Valneva SE's (NASDAQ:VALN)COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age. MHRA found that VLA2001 meets safety, quality, and effectiveness standards. This new marketing authorization comes in addition to the emergency use authorization,…

It is the sixth Covid jab to be given the go-ahead in the UK

The jab developed by the firm, which has a factory in Livingston near Edinburgh, is the sixth Covid-19 vaccine to be granted an MHRA authorisation.

First Minister Mark Drakeford says having another vaccine makes the system 'more resilient'

It comes as the number of deaths continues to rise

Deaths involving coronavirus in England and Wales are continuing to rise.

European medical cannabis company Cantourage has received two British government licenses that authorize the company to import medical cannabis into the UK. The company has also received the required regulatory registration to prescribe medical cannabis products to clients via a new facility, Cantourage Clinic.

Electrical problem triggers global safety alert on 2,000 Philips machines